The article "feasibility of transcatheter closure of secundum atrial septal defect in low weight infants under 2-year-old from a three-year retrospective cohort study" was reviewed.This article was a retrospective study to evaluate the feasibility of interventional treatment of atrial septal defects (asd) in low weight infants under 2-year-old.From january 2011 to december 2016, 793 secundum asd patients were divided into two groups: 665 were above 2-year-old and 128 were under 2-year-old.Transcatheter occluders from different manufacturers are associated with the study including beijing huayi shengjie asd occluder, lifetech scientific asd occluder, boat fit asd occluder, and abbott amplatzer septal occluder.There was no allegation of malfunction against the abbott device.The primary author is chunhui cao, md, department of cardiology, shenzhen hospital, southern medical university, guangdong, china.The corresponding author is zhiwei zhang, with corresponding email: drzhangzw@sohu.Com.
|
As reported in a research article, patients implanted with an amplatzer septal occluder included embolization of the device, headache, residual shunt, and arrythmia.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
|